Repaglinide

CAS 135062-02-1 13 current records 5 historicalSmall Molecule

Who holds supplier records for Repaglinide? 13 organisations hold a current record for Repaglinide: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 12 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (9), China (2), Germany (1) and Iceland (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Repaglinide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/repaglinide

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    9 of the 13 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Repaglinide. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Repaglinide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (12)

Certificates of Suitability on the EDQM register for Repaglinide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
JUBILANT BIOSYS LIMITED MysuruIN
CEP 2011-202 - Rev 02
Repaglinide
Mar 2026—
USV PRIVATE LIMITED MumbaiIN
CEP 2009-239 - Rev 03
Repaglinide, Form I
Aug 2025—
BIOCON LIMITED BengaluruIN
CEP 2008-093 - Rev 02
Repaglinide
Dec 2024—
ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO., LTD. Taizhou CityCN
CEP 2008-201 - Rev 06
Repaglinide
Apr 2024Inspected Jan 2024
Germany
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2008-044 - Rev 02
Repaglinide
Jan 2024—
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
R1-CEP 2012-087 - Rev 00
Repaglinide
Sept 2018—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2008-196 - Rev 03
Repaglinide
Jun 2018—
Torrent Pharmaceuticals Limited AhmedabadIN
R1-CEP 2011-308 - Rev 00
Repaglinide
Aug 2017—
ACTAVIS GROUP PTC EHF HafnarfjordurIS
R1-CEP 2010-304 - Rev 01
Repaglinide
Feb 2017—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
R1-CEP 2009-375 - Rev 01
Repaglinide
Jan 2016—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
R1-CEP 2006-069 - Rev 02
Repaglinide
May 2015—
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Ingelheim Am RheinDE
R1-CEP 2006-123 - Rev 00
Repaglinide
Sept 2012—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Repaglinide are no longer active. These show a past filing, not current supply.

Show all 5 historical records

Overview

Repaglinide is an oral medication used to manage Type 2 diabetes mellitus by stimulating the release of insulin from pancreatic beta cells. It is classified as a meglitinide and helps control blood sugar levels post-prandially.

Chemical identity

IUPAC name
2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid
Canonical SMILES
CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
InChIKey
FAEKWTJYAYMJKF-QHCPKHFHSA-N
Synonyms
Prandin API, a10bx02, ag-ee 623 zw, ag-ee-623-zw, ag-ee-623zw, agee-623zw, nsc-759893, prandin

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Glinide
Mechanism of action
Potassium Channel Antagonists

Therapeutic areas

DiabetesEndocrinology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Repaglinide?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Repaglinide: APITORIA PHARMA PRIVATE LTD (India), Biocon Limited (India), BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG (Germany), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India), JUBILANT BIOSYS LTD (India), Macleods Pharmaceuticals Ltd. (India) and Sun Pharmaceutical Industries Limited (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Repaglinide Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 23068), Biocon Limited (DMF 18482), BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG (DMF 19620), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 26396), Dr. Reddy's Laboratories Ltd. (DMF 17245), JUBILANT BIOSYS LTD (DMF 24519), Macleods Pharmaceuticals Ltd. (DMF 22234) and Sun Pharmaceutical Industries Limited (DMF 17825) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Repaglinide records mean?

5 organisations have only inactive Type II DMFs for Repaglinide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Repaglinide have a European Certificate of Suitability?

Yes. 12 organisations hold a valid CEP for Repaglinide on the EDQM register, including JUBILANT BIOSYS LIMITED Mysuru (IN), USV PRIVATE LIMITED Mumbai (IN), BIOCON LIMITED Bengaluru (IN), ZHEJIANG HISOAR CHUANNAN PHARMACEUTICAL CO., LTD. Taizhou City (CN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram (IN) and 6 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Repaglinide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Repaglinide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.